CollPlant Biotechnologies Ltd.
CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3Dā¦ read more
Healthcare
Biotechnology
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.52
Price+10.15%
$0.14
1Y
Price
Market Cap
$19.328m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-4233.8%
EBITDA Margin-4523.4%
Net Profit Margin-3737.7%
Free Cash Flow MarginRevenue
$2.475m
+380.6%
1y CAGR+1283.5%
3y CAGR+938.1%
5y CAGREarnings
-$12.160m
+26.8%
1y CAGR-17.1%
3y CAGR-1823.2%
5y CAGREPS
-$1.02
+29.7%
1y CAGR-15.0%
3y CAGR-1302.9%
5y CAGRBook Value
$9.305m
$14.089m
Assets$4.784m
Liabilities$2.940m
DebtDebt to Assets
20.9%
-0.3x
Debt to EBITDAFree Cash Flow
-$10.020m
+31.3%
1y CAGR-61.9%
3y CAGR-420.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company